Caspase 8
Caspase 8
Caspase 8 is a cysteine-aspartic acid protease that plays a crucial role in the apoptosis signaling pathways. It is an initiator caspase, meaning it is one of the first caspases activated in the cascade that leads to programmed cell death. Caspase 8 is encoded by the CASP8 gene in humans.
Structure
Caspase 8 is synthesized as an inactive proenzyme, which is then cleaved to form the active enzyme. The active form of caspase 8 consists of two large and two small subunits that form a heterotetramer. The enzyme contains a death effector domain (DED) that is important for its recruitment to the death-inducing signaling complex (DISC).
Function
Caspase 8 is primarily involved in the extrinsic pathway of apoptosis. It is activated by death receptors such as Fas receptor and TNF receptor. Upon activation, caspase 8 cleaves and activates downstream effector caspases, such as caspase 3, leading to the execution phase of apoptosis.
Role in Apoptosis
Caspase 8 is recruited to the DISC upon ligand binding to death receptors. This recruitment is mediated by the interaction of the DEDs of caspase 8 with the adaptor protein FADD (Fas-associated death domain). Once at the DISC, caspase 8 is activated through dimerization and autocatalytic cleavage.
Role in Necroptosis
In addition to its role in apoptosis, caspase 8 can inhibit necroptosis, a form of programmed necrosis. Caspase 8 cleaves and inactivates the kinase RIPK1 and RIPK3, which are essential for the execution of necroptosis.
Pathways
Caspase 8 is a key component of several signaling pathways, including the extrinsic apoptosis pathway and the TNF signaling pathway.
Clinical Significance
Mutations or dysregulation of caspase 8 can lead to various diseases. For example, reduced caspase 8 activity is associated with certain cancers, as it can lead to decreased apoptosis and increased cell survival. Conversely, excessive activation of caspase 8 can contribute to neurodegenerative diseases and other conditions characterized by excessive cell death.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD